Related references
Note: Only part of the references are listed.Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults A Randomized Clinical Trial
Sophia Liu et al.
JAMA NETWORK OPEN (2022)
Tricuspid Regurgitation in Left Ventricular Systolic Dysfunction: Marker or Target?
Davide Margonato et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Quality control of the mitochondrial proteome
Jiyao Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Mitochondrial quality surveillance as a therapeutic target in myocardial infarction
Hang Zhu et al.
ACTA PHYSIOLOGICA (2021)
Musculo-skeletal phenotype of Costello syndrome and cardio-facio-cutaneous syndrome: insights on the functional assessment status
Chiara Leoni et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy
Joshua C. Drake et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Multisystem mitochondrial diseases due to mutations in mtDNA-encoded subunits of complex I
Tereza Danhelovska et al.
BMC PEDIATRICS (2020)
Metabolic effects of bezafibrate in mitochondrial disease
Hannah Steele et al.
EMBO MOLECULAR MEDICINE (2020)
PGC-1α isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments
Melissa Leveille et al.
MOLECULAR METABOLISM (2020)
Stimulation of glycolysis promotes cardiomyocyte proliferation after injury in adult zebrafish
Ryuichi Fukuda et al.
EMBO REPORTS (2020)
The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
Jimin Yuan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Heart specific PGC-1 deletion identifies metabolome of cardiac restricted metabolic heart failure
Olli Karkkainen et al.
CARDIOVASCULAR RESEARCH (2019)
Mitochondrial DNA Variation Dictates Expressivity and Progression of Nuclear DNA Mutations Causing Cardiomyopathy
Meagan J. McManus et al.
CELL METABOLISM (2019)
Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia
Lauren R. Waskowicz et al.
HUMAN MOLECULAR GENETICS (2019)
Altered mitochondrial quality control in Atg7-deficient VSMCs promotes enhanced apoptosis and is linked to unstable atherosclerotic plaque phenotype
Hripsime Nahapetyan et al.
CELL DEATH & DISEASE (2019)
Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality
Jo Ishizawa et al.
CANCER CELL (2019)
Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
Diem H. Tran et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR
Caterina Collodet et al.
FASEB JOURNAL (2019)
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans
Penelope A. Andreux et al.
NATURE METABOLISM (2019)
MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure
Robin Verjans et al.
HYPERTENSION (2018)
RAS signalling in energy metabolism and rare human diseases
L. Dard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2018)
The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice
Caitlin Schafer et al.
FRONTIERS IN PHARMACOLOGY (2018)
Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis
Daiju Oba et al.
EBIOMEDICINE (2018)
AMPK2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation
Bei Wang et al.
CIRCULATION RESEARCH (2018)
Overexpression of miR-221 in sudden death with cardiac hypertrophy patients
Yu Kakimoto et al.
HELIYON (2018)
New and revisited approaches to preserving the reperfused myocardium
Robert A. Kloner et al.
NATURE REVIEWS CARDIOLOGY (2017)
The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome
Yan Huang et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
A reversible phospho-switch mediated by ULK1 regulates the activity of autophagy protease ATG4B
N. Pengo et al.
NATURE COMMUNICATIONS (2017)
Resveratrol attenuates ICAM-1 expression and monocyte adhesiveness to TNF-α-treated endothelial cells: evidence for an anti-inflammatory cascade mediated by the miR-221/222/AMPK/p38/NF-κBpathway
Chen-Wei Liu et al.
SCIENTIFIC REPORTS (2017)
Quantification of spatiotemporal patterns of Ras isoform expression during development
Anna U. Newlaczyl et al.
SCIENTIFIC REPORTS (2017)
Cardiac-Specific Overexpression of miR-222 Induces Heart Failure and Inhibits Autophagy in Mice
Ming Su et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Mitochondrial Function, Biology, and Role in Disease A Scientific Statement From the American Heart Association
Elizabeth Murphy et al.
CIRCULATION RESEARCH (2016)
Loss of CLPP alleviates mitochondrial cardiomyopathy without affecting the mammalian UPRmt
Dominic Seiferling et al.
EMBO REPORTS (2016)
Down-regulation of the mitochondrial matrix peptidase CIpP in muscle cells causes mitochondrial dysfunction and decreases cell proliferation
Sathyaseelan S. Deepa et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Urolithin A induces mitophagy and prolongs lifespan in C-elegans and increases muscle function in rodents
Dongryeol Ryu et al.
NATURE MEDICINE (2016)
Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy
Julian O. M. Ormerod et al.
NATURE REVIEWS CARDIOLOGY (2016)
A Novel HRAS Mutation Independently Contributes to Left Ventricular Hypertrophy in a Family with a Known MYH7 Mutation
Maria Elena Sana et al.
PLOS ONE (2016)
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Alicia Cole et al.
CANCER CELL (2015)
miR-222 Is Necessary for Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling
Xiaojun Liu et al.
CELL METABOLISM (2015)
Left ventricular diastolic dysfunction in Nrf2 knock out mice is associated with cardiac hypertrophy, decreased expression of SERCA2a, and preserved endothelial function
Ralf Erkens et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice
Timothy Wai et al.
SCIENCE (2015)
MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis
M. Su et al.
CELL DEATH AND DIFFERENTIATION (2015)
AMPK Modulates Tissue and Organismal Aging in a Non-Cell-Autonomous Manner
Matthew Ulgherait et al.
CELL REPORTS (2014)
Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRASG12D-driven lung tumors
Jessie Yanxiang Guo et al.
AUTOPHAGY (2013)
Cutaneous Manifestations in Costello and Cardiofaciocutaneous Syndrome: Report of 18 Cases and Literature Review
Fanny Morice-Picard et al.
PEDIATRIC DERMATOLOGY (2013)
Maintenance of mitochondrial genome distribution by mitochondrial AAA plus protein ClpX
Katsumi Kasashima et al.
EXPERIMENTAL CELL RESEARCH (2012)
Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntingtons disease
Ashu Johri et al.
HUMAN MOLECULAR GENETICS (2012)
Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice
Shuichi Yatsuga et al.
HUMAN MOLECULAR GENETICS (2012)
Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice
Magali Dumont et al.
HUMAN MOLECULAR GENETICS (2012)
Comparative analysis of human and mouse expression data illuminates tissue-specific evolutionary patterns of miRNAs
Julien Roux et al.
NUCLEIC ACIDS RESEARCH (2012)
Long-Term Bezafibrate Treatment Improves Skin and Spleen Phenotypes of the mtDNA Mutator Mouse
Lloye M. Dillon et al.
PLOS ONE (2012)
PGC-1 Proteins and Heart Failure
Christian Riehle et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2012)
Clinical, Pathological, and Molecular Analyses of Cardiovascular Abnormalities in Costello Syndrome: A Ras/MAPK Pathway Syndrome
Angela E. Lin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Species Differences in the Effects of Bezafibrate as a Potential Treatment of Mitochondrial Disorders
Fatima Djouadi et al.
CELL METABOLISM (2011)
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
Carlo Viscomi et al.
CELL METABOLISM (2011)
Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway
Tjitske Kleefstra et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
AMP Activated Protein Kinase-α2 Regulates Expression of Estrogen-Related Receptor-α, a Metabolic Transcription Factor Related to Heart Failure Development
Xinli Hu et al.
HYPERTENSION (2011)
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Maria M. Mihaylova et al.
NATURE CELL BIOLOGY (2011)
TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer
Susanna Stinson et al.
SCIENCE SIGNALING (2011)
Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle
Carles Canto et al.
CELL METABOLISM (2010)
Long-Term Follow-Up of Bezafibrate Treatment in Patients With the Myopathic Form of Carnitine Palmitoyltransferase 2 Deficiency
J. P. Bonnefont et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells
Cristina Santoriello et al.
DISEASE MODELS & MECHANISMS (2009)
AMPK: Lessons from transgenic and knockout animals
Benoit Viollet et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Cardiac-specific Deletion of LKB1 Leads to Hypertrophy and Dysfunction
Yasumasa Ikeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Bezafibrate at Clinically Relevant Doses Decreases Serum/Liver Triglycerides via Down-Regulation of Sterol Regulatory Element-Binding Protein-1c in Mice: A Novel Peroxisome Proliferator-Activated Receptor α-Independent Mechanism
Takero Nakajima et al.
MOLECULAR PHARMACOLOGY (2009)
Bezafibrate for an Inborn Mitochondrial Beta-Oxidation Defect
Jean-Paul Bonnefont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice
Ping Zhang et al.
HYPERTENSION (2008)
FoxO3 coordinately activates protein degradation by the Autophagic/Lysosomal and proteasomal pathways in atrophying muscle cells
Jinghui Zhao et al.
CELL METABOLISM (2007)
The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor
Eric L. Greer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The nuclear receptor ERRα is required for the bioenergetic and functional adaptation to cardiac pressure overload
Janice M. Huss et al.
CELL METABOLISM (2007)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-α-null hearts can be rescued by increasing glucose transport and utilization
I Luptak et al.
CIRCULATION (2005)
The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation
M Buzzai et al.
ONCOGENE (2005)
Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle
Z Arany et al.
CELL METABOLISM (2005)
Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells
R Rossignol et al.
CANCER RESEARCH (2004)
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia
IJ Jonkers et al.
JOURNAL OF HYPERTENSION (2001)
Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development
LM Esteban et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
